COVID-19: Buhari govt, Senate meet over vaccine purchase

News
Spread the love
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

The leadership of the Nigerian Senate has hinted that it will be engaging the Executive concerning the purchase of the COVID-19 vaccine.

This conclusion came after a meeting with the Executive where they looked at the possible ways to ensure the purchase of the vaccine in 2021.

The meeting presided over by the Senate President, Ahmad Lawan, also had Minister of Finance, Zainab Ahmed; Minister of Health, Dr. Osagie Ehanire; Minister of State for Health, Sen. Dr. Olorunimbe Mamora; Director-General, Budget, and National Planning, Ben Akabueze; Director-General, National Centre for Disease Control, Chikwe Ihekweazu; and Director-General, National Agency for Food and Drug Administration and Control (NAFDAC).

Speaking at the meeting, Senate President Lawan disclosed the meeting was to know how prepared the federal government is towards the purchase of COVID-19 purchase.

“Essentially, we want you to tell us how we are going to be able to provide the vaccines in such a manner that the vaccines are not only acquired but remain efficacious and effective, that they are not invalidated because of any challenge in the area of storage or during transportation. And we know ours is a very difficult and sometimes impossible environment.

“Other countries have already started receiving the vaccines, even though I’m not sure if there’s any African country that has received. But if any African country should receive first, it should be Nigeria.

“Alongside these, you should also give us an idea on how we are going to start the vaccination.

“We need to have the strategy of how we intend to do it so that we don’t run into any chaos,” Lawan said.

Please don’t forget to “Allow the notification” so you will be the first to get our gist when we publish it.

Drop your comment in the section below, and don’t forget to share this post.

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Leave a Reply